GSK3B and early-onset autosomal dominant Alzheimer disease: It was reported that overexpression of GSK-3β promotes abnormal hyperphosphorylation of tau protein, exacerbates neuronal degeneration, disrupts normal synaptic plasticity, and accelerates the pathological process in Alzheimer's disease patients (Hernandez et al. 2013).